Table 4.
Embryonic musculoskeletal system development following treatment of pregnant rats with khat: day 12 experiment.
| Treatment group | Somite number | Forelimb | Hindlimb |
|---|---|---|---|
| Control | 39.2 ± 0.9 | 0 | 0 |
| K250 | 38.9 ± 0.8 | 0 | 1 |
| K500 | 37.8 ± 1.1 | 0 | 1 |
| K750 | 35.8 ± 1 | 8.3a | 32a |
| Ad libitum control | 39.2 ± 1.9 | 0 | 0 |
K250: khat extract 250 mg/kg; K500: khat extract 500 mg/kg; K750: khat extract 250 mg/kg; results are summarized as mean ± SDM (ANOVA) or percentages of retarded development (chi-square); asignificantly different (p < 0.05) from ad libitum control and pair-fed control groups.